46
57
b9
16
10
87
2
15
2
1d
1e
1c
57
b9
16
Department of
58 Medical Ethics and Health Policy
58 Medical Ethics and Health Policy
cd
2
21
6
54
6
36
c
Department of Medical Ethics / People / Bekelman
2 37 5 2 49 16
19
1
49
2
8
1b
1d
18
36
4b
1d
2 29
1d
25
Justin E. Bekelman, M.D.
78
4b
Marietta and Howard Stoeckel Professor
7
69
Department: Radiation Oncology
4
1
b
1d
46
Contact information
4e
4
3
3
1d
4e
Department of Radiation Oncology
1e Abramson Cancer Center
23 Perelman School of Medicine
22 University of Pennsylvania
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
26
1e Abramson Cancer Center
23 Perelman School of Medicine
22 University of Pennsylvania
3e 3400 Civic Center Boulevard
Philadelphia, PA 19104
30
Office: (215) 662-7266
34 Fax: (215) 349-8975
24
f
34 Fax: (215) 349-8975
24
18
Publications
23 a
3
2
29
23 a
Links
a2 Search PubMed for articles
86 Penn Center for Cancer Care Innovation at the Abramson Cancer Center
c
4
b
1f
a2 Search PubMed for articles
86 Penn Center for Cancer Care Innovation at the Abramson Cancer Center
c
13
Education:
21 9 A.B. 41 (Princeton School of Public and International Affairs) c
3c Princeton University, Princeton, NJ, 1995.
21 9 M.D. c
4a Yale University School of Medicine, New Haven, CT, 2003.
c
3
3
3
3
8f
Permanent link21 9 A.B. 41 (Princeton School of Public and International Affairs) c
3c Princeton University, Princeton, NJ, 1995.
21 9 M.D. c
4a Yale University School of Medicine, New Haven, CT, 2003.
c
2 29
21
1e
1d
24
5e
71
8
281 Dr. Bekelman completed his undergraduate studies at Princeton University in the Princeton School of Public and International Affairs and his medical training at Yale University, Johns Hopkins, and Memorial Sloan Kettering Cancer Center. Previously, he was a management consultant at the Kalchas Group, advising senior executives of health care and insurance clients on corporate strategy. Dr. Bekelman also served as Special Assistant to the Under Secretary of Defense in the US Department of Defense. He is a board-certified radiation oncologist and practicing physician at the University of Pennsylvania Perelman School of Medicine.
e 29
27
Description of Clinical Expertise
3d1 Dr. Bekelman is a physician with and former Chief of the Genitourinary Oncology Service in the Department of Radiation Oncology at Penn Medicine. Penn Medicine's Department of Radiation Oncology, with locations in the greater Philadelphia region and New Jersey, is a world leader in patient care, cancer research, and education and offers today's latest technology and treatment options. Over the years, Penn Medicine and Penn Radiation Oncology have received many prestigious awards, honors, and recognition for our commitment to providing our patients with the highest quality clinical care. Dr. Bekelman specializes in the early detection, surveillance and treatment of prostate cancer. We work with clinical experts from urology, medical oncology, radiology, pathology, and advanced practice nursing to improve cancer control, outcomes, and quality of life for our patients. Dr. Bekelman also has expertise in the treatment of testicular and bladder cancer.71
Description of Research Expertise
5d5 Justin E. Bekelman, M.D., is the founding Director of the Penn Center for Cancer Care Innovation at the Abramson Cancer Center, the Marietta and Howard Stoeckel Professor of Radiation Oncology, Medicine, and Medical Ethics and Health Policy at the Perelman School of Medicine, Faculty in the Center for Health Incentives and Behavioral Economics, and Senior Fellow at the Leonard Davis Institute for Health Economics, all at the University of Pennsylvania. Dr. Bekelman leads research programs to improve the length and quality of life for patients with cancer. His research focuses on health care delivery, payment reform and cancer care transformation, integrating methods from the fields of innovation, epidemiology, clinical trials, health economics and public policy. Dr. Bekelman’s research has appeared in high-impact scientific journals and has been featured by media outlets in the United States, Canada, Europe, Asia, and Latin America. His work has been funded by the National Cancer Institute, the American Cancer Society, the Patient-Centered Outcomes Research Institute, the Commonwealth of Pennsylvania, and philanthropic sources. He has served as an advisor to the Centers for Medicare and Medicaid Services (CMS) on cancer care payment reform and innovation. Dr. Bekelman is an elected member of the American Society for Clinical Investigation and a member of the National Cancer Policy Forum of the National Academies of Science, Engineering, and Medicine.8
281 Dr. Bekelman completed his undergraduate studies at Princeton University in the Princeton School of Public and International Affairs and his medical training at Yale University, Johns Hopkins, and Memorial Sloan Kettering Cancer Center. Previously, he was a management consultant at the Kalchas Group, advising senior executives of health care and insurance clients on corporate strategy. Dr. Bekelman also served as Special Assistant to the Under Secretary of Defense in the US Department of Defense. He is a board-certified radiation oncologist and practicing physician at the University of Pennsylvania Perelman School of Medicine.
e 29
23
9f Bekelman JE and Lee WR: 6 Questions to Ask Before We Shorten Radiation Treatments for Intact Prostate Cancer 4b Int J Radiat Oncol Biol Phys 97(4): 718-721, 2017.
e9 Ojerholm E, Halpern SD, Bekelman JE: Default options: opportunities to improve quality and value in oncology. Journal of Clinical Oncology 34(16): 1844-7, 2016.
1c0 Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ: Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. JAMA 315(3): 272-283, 2016.
139 Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K: Effectiveness of Androgen Deprivation Therapy and Radiotherapy for Older Men with Locally Advanced Prostate Cancer. Journal of Clinical Oncology 33(7): 716-22, 2015.
129 Kalbasi A, Li J, Berman A, Swisher-McClure S, Smaldone M, Uzzo RG, Small DS, Mitra N, Bekelman JE: Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer. JAMA Oncology 1(7): 897-906, 2015.
15a Bekelman JE, Sylwestrzak G, Barron J, Liu J, Epstein AJ, Freedman G, Malin J, Emanuel EJ: Uptake and Costs of Hypofractionated vs. Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008 - 2013. JAMA 312(23): 2542-50, December 2014.
b9 Bekelman JE, Kim M, Emanuel EJ: Toward Accountable Cancer Care. JAMA Internal Medicine 173(11): 958-9, Jun 2013.
e1 Bekelman JE, Epstein AJ, Emanuel EJ: Single vs Multiple Fraction Radiotherapy for Bone Metastases from Prostate Cancer. JAMA 310(14): 1501-02, Oct 2013.
2c
7
1d
1f
Selected Publications
10b Yasaitis L, Polsky D*, Bekelman J*: Relation between Narrow Networks and Providers of Cancer Care. Journal of Clinical Oncology 35(27): 3131-3135, 2017 Notes: *Denotes equal author contribution.9f Bekelman JE and Lee WR: 6 Questions to Ask Before We Shorten Radiation Treatments for Intact Prostate Cancer 4b Int J Radiat Oncol Biol Phys 97(4): 718-721, 2017.
e9 Ojerholm E, Halpern SD, Bekelman JE: Default options: opportunities to improve quality and value in oncology. Journal of Clinical Oncology 34(16): 1844-7, 2016.
1c0 Bekelman JE, Halpern SD, Blankart CR, Bynum JP, Cohen J, Fowler R, Kaasa S, Kwietniewski L, Melberg HO, Onwuteaka-Philipsen B, Oosterveld-Vlug M, Pring A, Schreyögg J, Ulrich CM, Verne J, Wunsch H, Emanuel EJ: Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries. JAMA 315(3): 272-283, 2016.
139 Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K: Effectiveness of Androgen Deprivation Therapy and Radiotherapy for Older Men with Locally Advanced Prostate Cancer. Journal of Clinical Oncology 33(7): 716-22, 2015.
129 Kalbasi A, Li J, Berman A, Swisher-McClure S, Smaldone M, Uzzo RG, Small DS, Mitra N, Bekelman JE: Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer. JAMA Oncology 1(7): 897-906, 2015.
15a Bekelman JE, Sylwestrzak G, Barron J, Liu J, Epstein AJ, Freedman G, Malin J, Emanuel EJ: Uptake and Costs of Hypofractionated vs. Conventional Whole Breast Irradiation After Breast Conserving Surgery in the United States, 2008 - 2013. JAMA 312(23): 2542-50, December 2014.
b9 Bekelman JE, Kim M, Emanuel EJ: Toward Accountable Cancer Care. JAMA Internal Medicine 173(11): 958-9, Jun 2013.
e1 Bekelman JE, Epstein AJ, Emanuel EJ: Single vs Multiple Fraction Radiotherapy for Bone Metastases from Prostate Cancer. JAMA 310(14): 1501-02, Oct 2013.
2c